Harm Reduction Product Distribution in British Columbia

被引:5
作者
Harvard, Stephanie S. [1 ]
Hill, Warren D. [1 ]
Buxton, Jane A. [1 ,2 ]
机构
[1] BC Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada
来源
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE | 2008年 / 99卷 / 06期
关键词
Harm reduction; needle-exchange programs; British Columbia; substance abuse; intravenous;
D O I
10.1007/BF03403773
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: The British Columbia Centre for Disease Control (BCCDC) tracks the distribution of all harm reduction products subsidized by the BC government, including needles and syringes, sterile water vials, alcohol swabs, condoms, and lubricant. This study measures the distribution of harm reduction products in BC, identifies regional variation in distribution, and estimates the supply/demand ratio for needle and syringe units. Methods: Using three years of administrative data (2004-2006) from the BCCDC, the quantity of harm reduction products distributed was calculated by Health Service Delivery Area (HSDA). Regional hepatitis C virus (HCV) case report rates were calculated to reflect potential variation in IDU populations at the HSDA-level and the number of needle and syringe units distributed per reported case of HCV was calculated and ranked by HSDA. To compare the demand for sterile injecting equipment to the distribution, the number of illicit drug injections per year was approximated using established estimates of IDU populations in BC and Vancouver. Results: Marked regional variation exists in the rates of harm reduction product distribution per 100,000 residents aged 15-64. The average number of needle and syringe units distributed annually in BC from 2004-2006 was 5,382,933. The estimated number of injections per year in BC is 24,951,144, suggesting the province distributed 21.5% of the units required to cover all illicit drug injections in the province. Discussion: Harm reduction product distribution is not equitable between BC HSDAs. The current level of distribution of sterile injecting equipment is inadequate to provide a clean needle for every injection.
引用
收藏
页码:446 / 450
页数:5
相关论文
共 21 条
[1]   Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia [J].
Aceijas, Carmen ;
Hickman, Matthew ;
Donoghoe, Martin C. ;
Burrows, Dave ;
Stuikyte, Raminta .
ADDICTION, 2007, 102 (08) :1244-1250
[2]  
*BC CDC, 2004, BC HARM RED SUPPL SE
[3]  
*BC CDC, 2005, ENH HEP STRAIN SURV
[4]  
*BC MIN HLTH, 2004, BRIT COL COMM GUID
[5]  
*CAN COMM EP NETW, 2005, VANC DRUG US EP
[6]  
*CAN CTR SUBST AB, 2004, CAN ADD SURV 2004
[7]   Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia [J].
Fischer, Benedikt ;
Powis, Jeff ;
Cruz, Michelle Firestone ;
Rudzinski, Katherine ;
Rehm, Juergen .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (01) :29-32
[8]   Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators [J].
Hickman, M ;
Higgins, V ;
Hope, V ;
Bellis, M ;
Tilling, K ;
Walker, A ;
Henry, J .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2004, 58 (09) :766-771
[9]  
Patrick DM, 2001, CAN MED ASSOC J, V165, P889
[10]  
PRITHWISH D, 2007, J ACQ IMMUN DEF SYND, V46, P355